Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 35, 1921-1925, August 1, 1975]
© 1975 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leibovici, J.
Right arrow Articles by Davidai, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leibovici, J.
Right arrow Articles by Davidai, G.

Effects of High-Molecular Levan on the Growth and Spread of Lymphoma in AKR Mice1

Judith Leibovici, Yehudith Sinai, Moshe Wolman2 and Gyora Davidai

Department of Pathology, Tel-Aviv University Medical School, and Chaim Sheba Medical Center, Tel-Aviv [J. L., M. W., G. D.], and Israel Institute for Biological Research, Ness Ziona [Y. S.], Israel

Levan was shown to inhibit lymphoma development in AKR mice. Growth of tumor was inhibited at the site of injection and in metastases. Levan caused a decrease in the incidence of tumors, and it reduced pleomorphism, mitoses, and invasiveness of tumors in comparison to nonlevanized mice. Evidence of tumor cell destruction was observed in levanized mice. The effect of levan on tumor development was dose dependent.

1 Supported in part by a grant from the Israel Cancer Society and by a Student Grant from the California Foundation for Biochemical Research.

2 Established Investigator of the Chief Scientist's Bureau, Ministry of Health, Israel. To whom requests for reprints should be addressed, at the Chaim Sheba Medical Center, Tel-Hashomer, Israel.

Received 12/ 5/74. Accepted 4/14/75.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1975 by the American Association for Cancer Research.